Tuning tumor-specific T-cell activation: a matter of costimulation?

Trends Immunol. 2002 May;23(5):240-5. doi: 10.1016/s1471-4906(02)02180-4.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Abatacept
  • Antigens, CD
  • Antigens, Differentiation / immunology
  • Antigens, Tumor-Associated, Carbohydrate / immunology
  • B7-1 Antigen / immunology
  • CD28 Antigens / immunology
  • CTLA-4 Antigen
  • Humans
  • Immunoconjugates*
  • Immunotherapy, Adoptive* / methods
  • Lymphocyte Activation / immunology*
  • Neoplasms / immunology
  • Neoplasms / therapy*
  • T-Lymphocytes / immunology*

Substances

  • Antigens, CD
  • Antigens, Differentiation
  • Antigens, Tumor-Associated, Carbohydrate
  • B7-1 Antigen
  • CD28 Antigens
  • CTLA-4 Antigen
  • CTLA4 protein, human
  • Immunoconjugates
  • Abatacept